Scilex Holding Company Amortization of Debt Discount (Premium)
Scilex Holding Company (SCLX) reported Amortization of Debt Discount (Premium) of $16.90 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2022-11-04
- Scilex Holding Company amortization of debt discount (premium) for the quarter ending 2022-09-30 was $1.16K.
- Scilex Holding Company amortization of debt discount (premium) for the quarter ending 2022-06-30 was $8.28K.
- Scilex Holding Company amortization of debt discount (premium) for the quarter ending 2022-03-31 was $7.47K.
- Scilex Holding Company amortization of debt discount (premium) for fiscal 2021 was $1.83K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $9.44K derived: sum of 2 quarters · filed 2022-11-04 | $16.90K 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $8.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $15.75K 10-Q · filed 2022-08-12 | ||
| 2022-03-31 | $7.47K 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $1.83K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |